July 10, 2024
1 min watch
Save
VIDEO: AbbVie pursuing new, innovative approaches to eye care
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Doug Faunce, PhD, reviews AbbVie’s ongoing efforts in the eye care field.
“AbbVie remains strongly committed to eye care, especially across the areas of retina, glaucoma and corneal health,” Faunce, executive director and head of search and evaluation for eye care at AbbVie, said. “We’re especially proud of our partnership with Regenxbio, looking for new and innovative approaches to treat both neovascular as well as diabetic retinal conditions with potentially one-and-done options for patients.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Faunce reports being an employee of AbbVie.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.